Weil advised Charles River Laboratories on the antitrust aspects of its acquisition of Cognate BioServices, a leading cell and gene therapy contract development and manufacturing organization. Charles River first announced the deal on February 17, 2021 and the transaction closed on March 29, 2021.

Weil’s Antitrust team was led by of global Antitrust/Competition practice Head Steven Newborn and partners Brianne Kucerik and Vadim Brusser (in Washington, D.C.) and included counsel Nafees Saeed (London) and associate Kristin Sanford.